Benzinga | May 26, 2021 07:18AM EDT

BioLine Rx Q1 EPS $(0.02) Beats $(0.15) Estimate

BioLine Rx (NASDAQ:BLRX) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.15) by 86.67 percent. This is a 50 percent increase over losses of $(0.04) per share from the same period last year.